ETF Holdings Breakdown of KURA

News associated with KURA

Wells Fargo & Company MN Has $305,000 Holdings in Kura Oncology, Inc. (NASDAQ:KURA)

Wells Fargo & Company MN grew its stake in shares of Kura Oncology, Inc. (NASDAQ:KURA – Free Report) by 48.5% during the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 34,989 shares of the company’s stock after acquiring an additional 11,427 shares […] - 2025-05-07 09:20:47

Kura Oncology, Inc. (NASDAQ:KURA) Shares Purchased by MetLife Investment Management LLC

MetLife Investment Management LLC boosted its position in shares of Kura Oncology, Inc. (NASDAQ:KURA – Free Report) by 6.6% during the 4th quarter, Holdings Channel reports. The institutional investor owned 44,828 shares of the company’s stock after acquiring an additional 2,776 shares during the period. MetLife Investment Management LLC’s holdings in Kura Oncology were worth […] - 2025-05-07 08:28:47

Kura Oncology (NASDAQ:KURA) Given Buy Rating at HC Wainwright

HC Wainwright restated their buy rating on shares of Kura Oncology (NASDAQ:KURA – Free Report) in a research report report published on Monday morning,Benzinga reports. They currently have a $40.00 price objective on the stock. Several other brokerages also recently weighed in on KURA. JMP Securities reaffirmed a “market outperform” rating and set a $28.00 […] - 2025-04-29 07:28:55

Kura Oncology, Inc. (NASDAQ:KURA) Shares Sold by Corebridge Financial Inc.

Corebridge Financial Inc. reduced its stake in Kura Oncology, Inc. (NASDAQ:KURA – Free Report) by 7.0% during the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 36,050 shares of the company’s stock after selling 2,721 shares during the quarter. Corebridge Financial Inc.’s holdings […] - 2025-04-11 07:54:48

Kura Oncology (NASDAQ:KURA) Given Outperform Rating at Wedbush

Kura Oncology (NASDAQ:KURA – Get Free Report)‘s stock had its “outperform” rating reissued by Wedbush in a research note issued to investors on Tuesday,RTT News reports. They currently have a $36.00 price objective on the stock. A number of other equities analysts have also recently weighed in on KURA. UBS Group dropped their price target […] - 2025-04-10 07:54:43

Kura Oncology, Inc. (NASDAQ:KURA) Stock Position Increased by Teacher Retirement System of Texas

Teacher Retirement System of Texas lifted its stake in shares of Kura Oncology, Inc. (NASDAQ:KURA – Free Report) by 19.9% in the 4th quarter, HoldingsChannel.com reports. The fund owned 13,749 shares of the company’s stock after acquiring an additional 2,285 shares during the quarter. Teacher Retirement System of Texas’ holdings in Kura Oncology were worth […] - 2025-04-03 07:16:48

Financial Comparison: Kura Oncology (NASDAQ:KURA) & Repare Therapeutics (NASDAQ:RPTX)

Kura Oncology (NASDAQ:KURA – Get Free Report) and Repare Therapeutics (NASDAQ:RPTX – Get Free Report) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their valuation, dividends, earnings, risk, institutional ownership, profitability and analyst recommendations. Profitability This table compares Kura Oncology and […] - 2025-04-03 05:22:47

StockNews.com Upgrades Kura Oncology (NASDAQ:KURA) to “Buy”

StockNews.com upgraded shares of Kura Oncology (NASDAQ:KURA – Free Report) from a hold rating to a buy rating in a research report report published on Wednesday morning. KURA has been the subject of a number of other reports. Cantor Fitzgerald raised shares of Kura Oncology to a “strong-buy” rating in a research report on Tuesday, […] - 2025-03-27 07:00:50

Kura Oncology (NASDAQ:KURA) Stock Rating Lowered by StockNews.com

StockNews.com lowered shares of Kura Oncology (NASDAQ:KURA – Free Report) from a buy rating to a hold rating in a research note released on Tuesday. KURA has been the topic of a number of other research reports. Jefferies Financial Group lowered their target price on shares of Kura Oncology from $32.00 to $28.00 and set […] - 2025-03-19 06:52:47

20,331 Shares in Kura Oncology, Inc. (NASDAQ:KURA) Bought by AlphaQuest LLC

AlphaQuest LLC acquired a new position in shares of Kura Oncology, Inc. (NASDAQ:KURA – Free Report) during the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm acquired 20,331 shares of the company’s stock, valued at approximately $177,000. Several other large investors have also recently added to […] - 2025-03-17 08:04:56

Rhumbline Advisers Purchases 1,923 Shares of Kura Oncology, Inc. (NASDAQ:KURA)

Rhumbline Advisers boosted its position in Kura Oncology, Inc. (NASDAQ:KURA – Free Report) by 2.0% during the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 99,991 shares of the company’s stock after acquiring an additional 1,923 shares during the period. Rhumbline Advisers’ holdings […] - 2025-03-07 09:20:52

Kura Oncology (NASDAQ:KURA) Raised to “Strong-Buy” at Cantor Fitzgerald

Kura Oncology (NASDAQ:KURA – Get Free Report) was upgraded by analysts at Cantor Fitzgerald to a “strong-buy” rating in a research note issued to investors on Tuesday,Zacks.com reports. Several other research firms have also recently commented on KURA. HC Wainwright restated a “buy” rating and set a $40.00 target price on shares of Kura Oncology […] - 2025-03-06 08:20:01

Brokerages Set Kura Oncology, Inc. (NASDAQ:KURA) PT at $27.13

Shares of Kura Oncology, Inc. (NASDAQ:KURA – Get Free Report) have been assigned a consensus rating of “Moderate Buy” from the twelve analysts that are covering the firm, Marketbeat reports. Three research analysts have rated the stock with a hold recommendation, eight have issued a buy recommendation and one has assigned a strong buy recommendation […] - 2025-02-21 06:46:47

Barclays PLC Has $3.23 Million Stock Position in Kura Oncology, Inc. (NASDAQ:KURA)

Barclays PLC boosted its stake in shares of Kura Oncology, Inc. (NASDAQ:KURA – Free Report) by 104.5% in the 3rd quarter, according to its most recent Form 13F filing with the SEC. The fund owned 165,484 shares of the company’s stock after purchasing an additional 84,563 shares during the period. Barclays PLC’s holdings in Kura […] - 2025-02-11 08:42:48

Jennison Associates LLC Acquires Shares of 71,497 Kura Oncology, Inc. (NASDAQ:KURA)

Jennison Associates LLC acquired a new stake in Kura Oncology, Inc. (NASDAQ:KURA – Free Report) in the 4th quarter, HoldingsChannel.com reports. The institutional investor acquired 71,497 shares of the company’s stock, valued at approximately $623,000. Several other large investors also recently added to or reduced their stakes in KURA. Moody Aldrich Partners LLC lifted its […] - 2025-02-08 09:05:00

China Universal Asset Management Co. Ltd. Purchases 1,750 Shares of Kura Oncology, Inc. (NASDAQ:KURA)

China Universal Asset Management Co. Ltd. lifted its position in Kura Oncology, Inc. (NASDAQ:KURA – Free Report) by 11.9% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 16,489 shares of the company’s stock after buying an additional 1,750 shares during […] - 2025-02-04 08:53:04

KURA institutional holdings

Date	ETF ISIN/Name	Num Shares	Book value
2025-05-08	IE00BF4RFH31 (iShares MSCI World Small Cap UCITS ETF USD (Acc))	35,917	USD 215,502 5.9%
2025-05-08	IE00B3VWM098 (iShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc)	12,248	USD 73,488 5.9%
2025-05-08	IE00BYXG2H39 (iShares Nasdaq US Biotechnology UCITS ETF USD (Acc))	37,983	USD 227,898
2025-05-08	IE00BDZVHG35 (iShares Nasdaq US Biotechnology UCITS ETF USD (Dist))	37,983	USD 227,898 5.9%
2025-05-08	IE000T9EOCL3 (iShares MSCI World Small Cap ESG Enhanced UCITS ETF USD (Acc))	268	USD 1,608 5.9%
Total =		124,399	USD 746,394

Book value of shares is calculated on the adjusted close price of each day (row).

Back to Listing

Disclaimer